CN101850079B - Chinese medicament for treating asthma - Google Patents

Chinese medicament for treating asthma Download PDF

Info

Publication number
CN101850079B
CN101850079B CN2009102421536A CN200910242153A CN101850079B CN 101850079 B CN101850079 B CN 101850079B CN 2009102421536 A CN2009102421536 A CN 2009102421536A CN 200910242153 A CN200910242153 A CN 200910242153A CN 101850079 B CN101850079 B CN 101850079B
Authority
CN
China
Prior art keywords
asthma
chinese
parts
chinese medicine
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009102421536A
Other languages
Chinese (zh)
Other versions
CN101850079A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Huilong Vientiane Garden
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102421536A priority Critical patent/CN101850079B/en
Publication of CN101850079A publication Critical patent/CN101850079A/en
Application granted granted Critical
Publication of CN101850079B publication Critical patent/CN101850079B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating asthma, and belongs to the field of Chinese medicaments for treating respiratory diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as exocarpium citri rubrum, glossy ganoderma, Chinese angelica, swordlike atractylodes rhizome, radix pseudo-ginseng, coix seed and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, warming the lung and reducing phlegm and stopping asthma, and has the advantages of obvious effect, definite curative effect and quick response.

Description

A kind of Chinese medicine for the treatment of asthma
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
At present, be intended to treat the field of Chinese medicines of asthma, exist the deficiency of several aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Large quantities of asthma patients can not effectively treat and control this disease because of medicine, thus asthma is shown effect repeatedly, touching difficulty more, the patient is sound, unable to lie due to dyspnea in fullness in the chest with rough breath, the larynx usually, and is very painful.Family numbers of patients is very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of asthma, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of asthma adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Tangerine 4---30 parts of 30 portions of Ganodermas 2---12 parts of Radix Angelicae Sinensis 4---
Rhizoma Atractylodis 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Semen Coiciss 4---
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, dried tangerine peel, Radix Angelicae Sinensis, Rhizoma Atractylodis, Semen Coicis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We's special for treating spleen lung yang deficiency, the accumulatively wet raise phlegm cough-relieving is breathed heavily.Dried tangerine peel sputum-resolving promoting the circulation of QI in the side; Semen Coicis spleen invigorating eliminating dampness by diuresis; The Rhizoma Atractylodis the spleen strengthening and damp drying; Close with the Ganoderma benefiting QI and nourishing blood tranquilizing by nourishing the heart, training tonifying five ZANG-organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-supplementing blood-nourishing, blood circulation promoting and blood stasis dispelling strengthens trachea and lung tissue microcirculation, breathes heavily thereby alleviate expectoration.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of warming the lung for resolving phlegm Dingchuan, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Tangerine 80 kairine sesames, 40 gram Radix Angelicae Sinensis, 80 grams
Rhizoma Atractylodis 80 gram Radix Notoginseng 60 gram Semen Coiciss 80 grams
Weight in accordance with regulations, with conventional water extraction process dried tangerine peel, Radix Angelicae Sinensis, Rhizoma Atractylodis, Semen Coicis are extracted, make extractum fine powder 96 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 700 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Tangerine 150 kairine sesames, 60 gram Radix Angelicae Sinensis, 150 grams
Rhizoma Atractylodis 150 gram Radix Notoginseng 120 gram Semen Coiciss 150 grams
By above-mentioned same method, make 1285 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Tangerine 300 kairine sesames, 100 gram Radix Angelicae Sinensis, 300 grams
Rhizoma Atractylodis 300 gram Radix Notoginseng 180 gram Semen Coiciss 300 grams
By above-mentioned same method, make 2285 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 3 parts of Radix Angelicae Sinensis of tangerine 7 portions of Ganodermas
7 parts of 4 parts of Semen Coiciss of 7 portions of Radix Notoginseng of Rhizoma Atractylodis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 8 parts of Radix Angelicae Sinensis of tangerine 20 portions of Ganodermas
20 parts of 16 parts of Semen Coiciss of 20 portions of Radix Notoginseng of Rhizoma Atractylodis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science asthma, through 7 routine clinical observations.Selecting tcm diagnosis asthma is standard: patient's limb is soft weak, and is weak on one's body; Usually uncomfortable in chest, pant, cough, dyspnea; Asthma is seasonal outbreak, perhaps cold asthma, perhaps asthma of heat type; Fullness in the chest with rough breath during asthma, the sound pitch breath gushes unable to lie due to dyspnea.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 2 examples do not have other serious disease, and the age is 45 years old-78 years old, 71.1 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Uncomfortable in chest, cough, dyspnea are obviously alleviated; The asthma attack number of times reduces, and the time is shorter; Took in 2 months in advance, cold asthma or asthma of heat type outbreak probability reduce.
2, effective: body constitution strengthens, on one's body energetically; Uncomfortable in chest, pant, cough, dyspnea alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. a Chinese medicine for the treatment of asthma adopts the raw material of Chinese medicine preparation, and prescription is by weight:
Tangerine 4---30 parts of 30 portions of Ganodermas 2---12 parts of Radix Angelicae Sinensis 4---
Rhizoma Atractylodis 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Semen Coiciss 4---
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, dried tangerine peel, Radix Angelicae Sinensis, Rhizoma Atractylodis, Semen Coicis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102421536A 2009-12-09 2009-12-09 Chinese medicament for treating asthma Active CN101850079B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102421536A CN101850079B (en) 2009-12-09 2009-12-09 Chinese medicament for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102421536A CN101850079B (en) 2009-12-09 2009-12-09 Chinese medicament for treating asthma

Publications (2)

Publication Number Publication Date
CN101850079A CN101850079A (en) 2010-10-06
CN101850079B true CN101850079B (en) 2011-11-23

Family

ID=42801869

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102421536A Active CN101850079B (en) 2009-12-09 2009-12-09 Chinese medicament for treating asthma

Country Status (1)

Country Link
CN (1) CN101850079B (en)

Also Published As

Publication number Publication date
CN101850079A (en) 2010-10-06

Similar Documents

Publication Publication Date Title
CN101884731B (en) Traditional Chinese medicine for treating silicosis
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101897847B (en) Traditional Chinese medicine for curing asthma
CN101850017B (en) Chinese medicament for treating asthma
CN101850079B (en) Chinese medicament for treating asthma
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN101884762B (en) Traditional Chinese medicine for treating emphysema
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101850083B (en) Chinese medicament for treating asthma
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101850018A (en) Chinese medicament for treating cervical spondylosis
CN101537068B (en) Chinese medicine for treating angina
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101850014B (en) Chinese medicament for treating asthma
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101850034B (en) Chinese medicament for treating angina
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus
CN101843866A (en) Chinese medicament for treating diabetic feet
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20131108

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226299 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131108

Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side)

Patentee after: Qidong Huilong Vientiane Garden

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.